MedPath
HSA Approval

VALACICLOVIR PHARMATHEN INTERNATIONAL FILM-COATED TABLETS 500MG

SIN14832P

VALACICLOVIR PHARMATHEN INTERNATIONAL FILM-COATED TABLETS 500MG

VALACICLOVIR PHARMATHEN INTERNATIONAL FILM-COATED TABLETS 500MG

August 24, 2015

SEA PHARMA CONSULTANCY PTE LTD

SEA PHARMA CONSULTANCY PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSEA PHARMA CONSULTANCY PTE LTD
Licence HolderSEA PHARMA CONSULTANCY PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J05AB11

valaciclovir

Manufacturer Information

SEA PHARMA CONSULTANCY PTE. LTD.

PHARMATHEN S.A.

Active Ingredients

Valacyclovir HCI hydrated 614.60mg eqv. to Valacyclovir

500mg

Valaciclovir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VALACICLOVIR PHARMATHEN INTERNATIONAL FILM-COATED TABLETS 500MG - HSA Approval | MedPath